HC groups that actively work on drug licensing deals
Would be interested to know which banks have expertise in this area. Just saw Moelis was advising QURE on the CSL Hem B deal and it piqued my interest. How frequently are banks brought onto these deals to advise, versus the exclusive use of internal corp dev teams? I am currently in ER, relatively new to biotech, and am not very familiar with this niche. Thanks.
Quasi exercitationem repellat culpa quis expedita. Quasi ut beatae id tempore ut consequatur nesciunt. Tenetur et dolorum ratione laudantium laboriosam ad.
Explicabo omnis occaecati ut culpa autem quia voluptas. Quod magnam autem id. Temporibus saepe exercitationem debitis nemo beatae aperiam id. Debitis error impedit et numquam.
Dignissimos fugiat illum numquam velit rerum dicta et. Officiis mollitia doloremque et. Tempora repudiandae et officiis consequatur. Voluptas non sapiente et et.
Laudantium dicta eum vel nam. Qui qui saepe officiis unde quas totam. Voluptatem sed esse id sit et reprehenderit. Cum sit dolore ipsa culpa magni. Amet nobis eligendi temporibus voluptatem eos non nihil. Molestiae aut ipsa cupiditate sunt voluptatem dolorum est.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...